CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-27 | Lamothe Jeffrey G. SVP and CFO | Grant or award · Stock Option (right to buy) | +2,140 | 2,140 | ||
| 2020-07-27 | Harsanyi Zsolt Director | Returned to the company · Stock Option (right to buy) | −1,339 | 0 | ||
| 2020-07-27 | Harsanyi Zsolt Director | Returned to the company · Stock Option (right to buy) | −892 | 0 | ||
| 2020-07-27 | Harsanyi Zsolt Director | Returned to the company · Stock Option (right to buy) | −1,785 | 0 | ||
| 2020-07-27 | Harsanyi Zsolt Director | Grant or award · Stock Option (right to buy) | +1,322 | 1,322 | ||
| 2020-07-27 | Harsanyi Zsolt Director | Grant or award · Stock Option (right to buy) | +170 | 170 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −2,072 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −2,779 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −3,908 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −2,407 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −2,407 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −4,814 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Returned to the company · Stock Option (right to buy) | −4,814 | 0 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +7,784 | 7,784 | ||
| 2020-07-27 | Gross Jane A SVP & Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +2,140 | 2,140 | ||
| 2020-07-27 | White Marvin L CEO and President | Returned to the company · Stock Option (right to buy) | −2,545 | 0 | ||
| 2020-07-27 | White Marvin L CEO and President | Returned to the company · Stock Option (right to buy) | −14,319 | 0 | ||
| 2020-07-27 | White Marvin L CEO and President | Returned to the company · Stock Option (right to buy) | −5,414 | 0 | ||
| 2020-07-27 | White Marvin L CEO and President | Returned to the company · Stock Option (right to buy) | −5,414 | 0 | ||
| 2020-07-27 | White Marvin L CEO and President | Returned to the company · Stock Option (right to buy) | −10,828 | 0 |
Page 15 of 27 · 523 trades